Home

About

Advanced Search

Browse by Discipline

Scientific Societies

E-print Alerts

Add E-prints

E-print Network
FAQHELPSITE MAPCONTACT US


  Advanced Search  

 
Radiotherapy and Dosimetry of 64 Cu-TETA-Tyr3
 

Summary: Radiotherapy and Dosimetry of 64
Cu-TETA-Tyr3
-Octreotate in a
Somatostatin Receptor-positive, Tumor-bearing Rat Model1
Jason S. Lewis, Michael R. Lewis,
P. Duffy Cutler, Ananth Srinivasan,
Michelle A. Schmidt, Sally W. Schwarz,
Margaret M. Morris, J. Philip Miller, and
Carolyn J. Anderson2
Mallinckrodt Institute of Radiology, Washington University School of
Medicine, St. Louis, Missouri 63110 [J. S. L., M. R. L., P. D. C.,
S. W. S., M. M. M., C. J. A.]; Division of Biostatistics, Washington
University School of Medicine, St. Louis, Missouri 63110 [J. P. M.];
and Mallinckrodt, Inc., Hazelwood, Missouri 63042 [A. S., M. A. S.]
ABSTRACT
64
Cu [T1/2 12.8 h; 0.655 MeV (19%);
0.573 MeV (40%)] has shown promise as a radioisotope for
targeted radiotherapy. It has been demonstrated previously
that the somatostatin analogue 64

  

Source: Anderson, Carolyn J. - Department of Molecular Biology and Pharmacology, Washington University in St. Louis

 

Collections: Biology and Medicine